HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kento Sakashita Selected Research

Therapeutics

9/2022Favorable Outcome with Intravenous Immunoglobulin Therapy in Late-Onset Anti-mGluR1 Encephalitis: A Case Report and Literature Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kento Sakashita Research Topics

Disease

1Cerebellar Diseases (Cerebellar Syndrome)
09/2022
1Encephalitis (Encephalitis, Rasmussen)
09/2022
1Sudden Death
01/2022
1Infections
01/2022
1Multiple System Atrophy
01/2022

Drug/Important Bio-Agent (IBA)

1Intravenous Immunoglobulins (IVIG)FDA Link
09/2022
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
09/2022
1metabotropic glutamate receptor type 1IBA
09/2022

Therapy/Procedure

1Immunomodulation
09/2022
1Therapeutics
09/2022
1Tracheostomy
01/2022